Dengue outbreak in the Americas compels WHO to approve second vaccine
GENEVA, Switzerland: The World Health Organization (WHO) has authorized a second vaccine against dengue as outbreaks continue to surge across the Americas.
The newly approved vaccine, developed by Japanese pharmaceutical company Takeda, is recommended for children aged six to 16 years in areas with high rates of the disease. Known as Qdenga, this two-dose vaccine offers protection against all four types of deng